The role of Bifidobacterium lactis B94 plus inulin in the treatment of acute infectious diarrhea in children

Turkish Journal of Gastroenterology

Volumn 25, Issue 6, 2014, Pages 628-633

  Işlek, Ali ^a   Sayar, Ersin ^a   Yilmaz, Aygen ^a   Baysan, Betil Ozhak ^a   Mutlu, Derya ^a   Artan, Reha ^a  

^a AKDENIZ UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Acute gastroenteritis; Bifidobacterium lactis B94; Childhood; Inulin

Indexed keywords

BIFIDOBACTERIUM LACTIS B94; INULIN; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; PREBIOTIC AGENT;

ACUTE DIARRHEA; ADENOVIRIDAE; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CAMPYLOBACTER; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOSPORIDIUM; DRUG EFFECT; ENTAMOEBA HISTOLYTICA; FECES CULTURE; FEMALE; HUMAN; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; MALE; PEPTOCLOSTRIDIUM DIFFICILE; ROTAVIRUS; SALMONELLA; SHIGELLA; ACUTE DISEASE; BIFIDOBACTERIUM; DIARRHEA; GASTROENTERITIS; MICROBIOLOGY; PRESCHOOL CHILD;

ACUTE DISEASE; BIFIDOBACTERIUM; CHILD, PRESCHOOL; DIARRHEA; FEMALE; GASTROENTERITIS; HUMANS; INFANT; INULIN; MALE; PREBIOTICS;

EID: 84920422555     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.5152/tjg.2014.14022     Document Type: Article

References (32)

1. Koletzko S, Osterrieder S. Acute infectious diarrhea in children. Dtsch Arzetbl Int 2009; 106: 539-47.
2. Walker CL, Rudan I, Liu L, et al. Global burden of childhood pneumonia and diarrhoea. Lancet 2013; 20; 381: 1405-16.
3. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 2014; 11: 506-14.
4. Kullen MJ, Bettler J. The delivery of probiotics and prebiotics to infants. Curr Pharm Des 2005; 11: 55-74.
5. Michail S, Sylvester F, Fuchs G, Issenman R. Clinical efficacy of probiotics: review of the evidence with focus on children. J Pediatr Gastroenterol Nutr 2006; 43: 550-7.
6. Szajewska H, Guarino A, Hojsak I, Indrio F, Kolacek S, Shamir R, Vandenplas Y, Weizman Z. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J Pediatr Gastroenterol Nutr 2014; 58: 531-9.
7. De Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K. Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharmacol Ther 2006; 23: 963-74.
8. Cabana MD, Shane AL, Chao C, Oliva-Henker M. Probiotics in primary care pediatrics. Clin Pediatr 2006; 45: 405-10.
9. Fedorak RN, Madsen KI. Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 2004; 20: 146-55.
10. Michail S, Abernathy F. Lactobacillus plantarum reduces thein vitro secretory response of intestinal epithelial cells in enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 2002; 35: 350-5.
11. Link-Amster H, Rochat F, Saudan KY, Mignot O, Aeschlimann JM. Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake. FEMS Immunol Med Microbiol 1994; 10: 55-64.
12. Arunachalam K, Gill HS, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of Bifidobacteria lactis (HN019). Eur J Clin Nutr 2000; 54: 263-7.
13. Kalia M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res 1992; 32: 141-4.
14. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebocontrolled trials. J Pediatr Gastroenterol Nutr 2001; 33: 17-25.
15. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2003;(4): CD003048.
16. Macfarlane GT, Steed H, Macfarlane S. Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 2008; 104: 305-44.
17. Wallace B. Clinical Use of Probiotics in the Pediatric Population. Nutr Clin Pract 2009; 24: 50-9.
18. Senok AC, Ismaeel AY, Botta GA. Probiotics: facts and myths. Clin Microbiol Infect 2005; 11: 958-66.
19. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev 2010; CD003048.
20. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Białek D. Metaanalysis: Lactobacillus GG for treating acute gastroenteritis in children updated analysis of randomised controlled trials. Aliment Pharmacol Ther 2013; 38: 467-76.
21. Szajewska H, Skorka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-Analysis of randomized controlled trials. Aliment Pharmacol Ther 2009; 30: 955-63.
22. Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 2012; 12: 395-410.
23. Szajewska H, Urbanska M, Chmielewska A, Weizman Z, Shamir R. Meta-Analysis: Lactobacillus reuteri strain DSM 17938 (and the original strain ATCC 55730) for treating acute gastroenteritis in children. Benef Microbes 2014; 24: 1-9.
24. Szajewska H, Ruszczynski M, Kolacek S. Meta-Analysis shows limited for using Lactobacillus acidophilus LB to treat acute gastroenteritis in children. Acta Paediatr 2014; 103: 249-55.
25. Huang YF, Liu PY, Chen YY Nong BR, et al. Three-combination probiotics therapy in children with salmonella and rotavirus gastroenteritis. J Clin Gastroenterol 2014; 48: 37-42.
26. Grandy G, Medina M, Soria R, Teran CG, Araya M. Probiotics in the treatment of acute rotavirus diarrhoea. A randomized, doubleblind, controlled trial using two different probiotic preparations in Bolivian children. BMC Infect Dis 2010; 10: 253.
27. Foster LM, Tompkins TA, Dahl WJ. A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011. Benef Microbes 2011; 2: 319-34.
28. Rerksuppaphol S, Rerksuppaphol. L. Lactobacillus acidophilus and Bifidobacterium bifidum stored at ambient temperature are effective in the treatment of acute diarrhoea. Ann Trop Paediatr 2010; 30: 299-304.
29. Vandenplas Y. Oligosaccharides in infant formula. Br J Nutr 2002; 87: 293-6.
30. Knol J, Boehm G, Lidestri M, et al. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Acta Paediatr 2005; 94: 31-3.
31. Bakker ZAM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindel JG. Effects of infant formula containing a mixture of galacto-And fructooligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr 2005; 94: 783-90.
32. Braegger C, Chmielewska A, Decsi T, et al. Supplementation of infant formula with probiotics and/or prebiotics: A systematic review and comment by the ESPGHAN committee on nutrition. J Pediatr Gastroenterol Nutr 2011; 52: 238-50.